Kiniksa Pharmaceuticals (KNSA) Stock Chart & Stock Price History $21.21 +0.39 (+1.87%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kiniksa Pharmaceuticals Stock Price Performance 5 Day Performance-0.38%1 Month Performance-18.06%3 Month Performance-19.75%6 Month Performance+9.50%Year-To-Date Performance+20.92%1 Year Performance+33.23% Receive KNSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. KNSA Stock Chart for Thursday, November, 21, 2024 KNSA Chart by TradingView Kiniksa Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$20.82$21.21+1.87%$21.55$20.41245,586 shs$1.53 billion11/19/2024$21.50$20.82-3.16%$21.50$20.62309,220 shs$1.50 billion11/18/2024$21.29$21.50+0.99%$21.52$20.58337,633 shs$1.55 billion11/15/2024$21.81$21.29-2.38%$21.96$21.13259,867 shs$1.54 billion11/14/2024$22.62$21.81-3.58%$22.57$21.71218,423 shs$1.57 billion11/13/2024$22.99$22.62-1.61%$23.34$22.56234,109 shs$1.63 billion Get the Latest News and Ratings for KNSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$23.04$22.99-0.22%$23.33$22.66427,547 shs$1.66 billion11/11/2024$22.86$23.04+0.79%$23.52$22.86317,327 shs$1.66 billion11/08/2024$23.01$22.86-0.65%$23.36$22.62353,800 shs$1.63 billion11/07/2024$23.03$23.01-0.09%$23.42$22.68314,310 shs$1.64 billion11/06/2024$22.03$23.03+4.54%$23.17$22.17505,808 shs$1.64 billion11/05/2024$21.48$22.03+2.56%$22.14$20.66373,477 shs$1.57 billion11/04/2024$22.48$21.48-4.43%$22.26$21.44443,997 shs$1.53 billion11/01/2024$22.59$22.48-0.51%$23.37$22.26358,298 shs$1.60 billion10/31/2024$23.01$22.59-1.83%$23.20$22.34412,709 shs$1.61 billion10/30/2024$23.27$23.01-1.10%$23.86$23.00357,720 shs$1.64 billion10/29/2024$27.59$23.27-15.68%$25.36$20.26981,731 shs$1.65 billion10/28/2024$27.44$27.59+0.55%$28.15$27.37342,389 shs$1.96 billion10/25/2024$26.92$27.44+1.93%$27.67$26.83204,259 shs$1.95 billion10/24/2024$26.84$26.92+0.30%$26.97$26.33248,782 shs$1.91 billion10/23/2024$26.79$26.84+0.19%$27.45$26.45223,055 shs$1.90 billion10/22/2024$25.89$26.79+3.50%$27.00$25.67219,769 shs$1.90 billion10/21/2024$26.26$25.89-1.43%$26.33$25.68242,723 shs$1.84 billion Related Companies Ocular Therapeutix Stock Price Chart Innoviva Stock Price Chart Arcutis Biotherapeutics Stock Price Chart Supernus Pharmaceuticals Stock Price Chart Pliant Therapeutics Stock Price Chart Theravance Biopharma Stock Price Chart Blueprint Medicines Stock Price Chart Nuvalent Stock Price Chart Viking Therapeutics Stock Price Chart Lantheus Stock Price Chart Receive KNSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kiniksa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KNSA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNSA Stock Alerts